表紙
市場調査レポート

迷走神経刺激装置:パイプライン分析

Vagus Nerve Stimulators - Pipeline Review, 2015

発行 GlobalData 商品コード 345364
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
迷走神経刺激装置:パイプライン分析 Vagus Nerve Stimulators - Pipeline Review, 2015
出版日: 2015年10月19日 ページ情報: 英文 90 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている迷走神経刺激装置のパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を盛り込んでいます。

第1章 目次

第2章 イントロダクション

  • 迷走神経刺激装置の概要

第3章 開発中の製品

  • 迷走神経刺激装置 - 開発段階別のパイプライン製品
  • 迷走神経刺激装置 - 国 (地域) 別のパイプライン製品
  • 迷走神経刺激装置 - 規制別のパイプライン製品
  • 迷走神経刺激装置 - 認証時期別 (推定) のパイプライン製品
  • 迷走神経刺激装置 - 現在進行中の治験

第4章 迷走神経刺激装置 - 開発中のパイプライン製品:企業別

  • 迷走神経刺激装置企業 - 開発段階別のパイプライン製品
  • 迷走神経刺激装置 - 開発段階別のパイプライン製品

第5章 迷走神経刺激装置企業と製品の概要

  • BioControl Medical
  • Boston Scientific Corporation
  • CerboMed GmbH
  • Cerebral RX Ltd.
  • Children's Hospital Boston
  • Cyberonics, Inc.
  • DuoCure Ltd.
  • ElectroCore, LLC
  • Medical University of South Carolina
  • MicroTransponder Inc.
  • Neurostream Technologies G.P.
  • Setpoint Medical Corporation
  • Sorin S.p.A.
  • Trifectas Medical Corp.

第6章 迷走神経刺激装置 - 最近の動向

第7章 付録

目次
Product Code: GDME0096EPD

GlobalData's Medical Devices sector report, "Vagus Nerve Stimulators - Pipeline Review, 2015" provides an overview of Vagus Nerve Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vagus Nerve Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Vagus Nerve Stimulators Overview

3. Products under Development

  • 3.1. Vagus Nerve Stimulators - Pipeline Products by Stage of Development
  • 3.2. Vagus Nerve Stimulators - Pipeline Products by Territory
  • 3.3. Vagus Nerve Stimulators - Pipeline Products by Regulatory Path
  • 3.4. Vagus Nerve Stimulators - Pipeline Products by Estimated Approval Date
  • 3.5. Vagus Nerve Stimulators - Ongoing Clinical Trials

4. Vagus Nerve Stimulators - Pipeline Products under Development by Companies

  • 4.1. Vagus Nerve Stimulators Companies - Pipeline Products by Stage of Development
  • 4.2. Vagus Nerve Stimulators - Pipeline Products by Stage of Development

5. Vagus Nerve Stimulators Companies and Product Overview

  • 5.1. BioControl Medical Company Overview
    • 5.1.1. BioControl Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Boston Scientific Corporation Company Overview
    • 5.2.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. CerboMed GmbH Company Overview
    • 5.3.1. CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Cerebral RX Ltd. Company Overview
    • 5.4.1. Cerebral RX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Children's Hospital Boston Company Overview
    • 5.5.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Cyberonics, Inc. Company Overview
    • 5.6.1. Cyberonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. DuoCure Ltd. Company Overview
    • 5.7.1. DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. ElectroCore, LLC Company Overview
    • 5.8.1. ElectroCore, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Medical University of South Carolina Company Overview
    • 5.9.1. Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. MicroTransponder Inc. Company Overview
    • 5.10.1. MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Neurostream Technologies G.P. Company Overview
    • 5.11.1. Neurostream Technologies G.P. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Setpoint Medical Corporation Company Overview
    • 5.12.1. Setpoint Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Sorin S.p.A. Company Overview
    • 5.13.1. Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Trifectas Medical Corp. Company Overview
    • 5.14.1. Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview

6. Vagus Nerve Stimulators- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Vagus Nerve Stimulators - Pipeline Products by Stage of Development
  • Table 2: Vagus Nerve Stimulators - Pipeline Products by Territory
  • Table 3: Vagus Nerve Stimulators - Pipeline Products by Regulatory Path
  • Table 4: Vagus Nerve Stimulators - Pipeline Products by Estimated Approval Date
  • Table 5: Vagus Nerve Stimulators - Ongoing Clinical Trials
  • Table 6: Vagus Nerve Stimulators Companies - Pipeline Products by Stage of Development
  • Table 7: Vagus Nerve Stimulators - Pipeline Products by Stage of Development
  • Table 8: BioControl Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: CardioFit System - Product Status
  • Table 10: CardioFit System - Product Description
  • Table 11: BioControl Medical - Ongoing Clinical Trials Overview
  • Table 12: CardioFit System - Increase of Vagal Tone in CHF (INOVATE-HF): A Randomized Study to Establish the Safety and Efficacy of CardioFit for the Treatment of Subjects with Heart Failure and Left Ventricular Dysfunction
  • Table 13: CardioFit System - Long-term Treatment Strength With CardioFit System To Assess Safety And Efficacy In Heart Failure Patients
  • Table 14: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: AMT System - Product Status
  • Table 16: AMT System - Product Description
  • Table 17: Vagal Nerve Stimulator - Product Status
  • Table 18: Vagal Nerve Stimulator - Product Description
  • Table 19: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 20: Vagal Nerve Stimulator - Neural Cardiac Therapy for Heart Failure Study
  • Table 21: CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: t-VNS - Dementia - Product Status
  • Table 23: t-VNS - Dementia - Product Description
  • Table 24: Cerebral RX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: FitNes System - Alzheimer's Disease - Product Status
  • Table 26: FitNes System - Alzheimer's Disease - Product Description
  • Table 27: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: VNS Device - Product Status
  • Table 29: VNS Device - Product Description
  • Table 30: Cyberonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Aspire NP - Product Status
  • Table 32: Aspire NP - Product Description
  • Table 33: Centro Generator - Product Status
  • Table 34: Centro Generator - Product Description
  • Table 35: CentroSR Generator - Product Status
  • Table 36: CentroSR Generator - Product Description
  • Table 37: Griffin - Pulse Generator - Product Status
  • Table 38: Griffin - Pulse Generator - Product Description
  • Table 39: Nerve Wrap - Product Status
  • Table 40: Nerve Wrap - Product Description
  • Table 41: PhoenixRF SR - Product Status
  • Table 42: PhoenixRF SR - Product Description
  • Table 43: VITARIA System - Chronic Heart Failure - Product Status
  • Table 44: VITARIA System - Chronic Heart Failure - Product Description
  • Table 45: Cyberonics, Inc. - Ongoing Clinical Trials Overview
  • Table 46: VITARIA System - Chronic Heart Failure - VITARIA Registry Study
  • Table 47: DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Intraluminal Implantable Device - Product Status
  • Table 49: Intraluminal Implantable Device - Product Description
  • Table 50: ElectroCore, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: AlphaCore - Product Status
  • Table 52: AlphaCore - Product Description
  • Table 53: GammaCore - Cluster Headache - Product Status
  • Table 54: GammaCore - Cluster Headache - Product Description
  • Table 55: GammaCore - Medication Overuse Headache - Product Status
  • Table 56: GammaCore - Medication Overuse Headache - Product Description
  • Table 57: GammaCore - Migraine - Product Status
  • Table 58: GammaCore - Migraine - Product Description
  • Table 59: ElectroCore, LLC - Ongoing Clinical Trials Overview
  • Table 60: AlphaCore - Evaluation of the Effect of the AlphaCore on Breathlessness and Time to Discharge in Hospitalised Subjects With COPD
  • Table 61: AlphaCore - Non-Invasive Vagus Nerve Stimulation With the AlphaCore Device for Management of Bronchoconstriction in Patients Hospitalized With COPD
  • Table 62: GammaCore - Migraine - A Randomized, Multi-center, Double-blind, Parallel, Crossover Study of a Non-invasive Neurostimulation to the Vagus Nerve With the GammaCore Device for the Reduction in Frequency of Seizures Associated With Epilepsy
  • Table 63: GammaCore - Migraine - Non-invasive Neurostimulation Of The Vagus Nerve With The GammaCore Device For The Prevention Of Chronic Migraine
  • Table 64: GammaCore - Cluster Headache - A Randomized, Multi-center Study for the Prevention and Acute Treatment of Chronic Cluster Headache Using Gammacore, Versus Standard of Care
  • Table 65: GammaCore - Cluster Headache - A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of the gammaCore, a Non-invasive Neurostimulator Device, for the Prevention of Episodic Migraine
  • Table 66: GammaCore - Cluster Headache - Non-Invasive Vagus Nerve Stimulation Treatment for Headache Using GammaCore
  • Table 67: GammaCore - Cluster Headache - Prevention and Acute Treatment of Chronic Cluster Headache Study (PREVA)
  • Table 68: Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Transcutaneous Auricular Vagus Nerve Stimulator (taVNS) - Product Status
  • Table 70: Transcutaneous Auricular Vagus Nerve Stimulator (taVNS) - Product Description
  • Table 71: MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: SAINT System - Anxiety Disorders - Product Status
  • Table 73: SAINT System - Anxiety Disorders - Product Description
  • Table 74: SAINT System - Tinnitus - Product Status
  • Table 75: SAINT System - Tinnitus - Product Description
  • Table 76: Serenity System - Post Stroke Motor Rehabilitation - Product Status
  • Table 77: Serenity System - Post Stroke Motor Rehabilitation - Product Description
  • Table 78: Serenity System - Tinnitus - Product Status
  • Table 79: Serenity System - Tinnitus - Product Description
  • Table 80: Vivistim Device - Product Status
  • Table 81: Vivistim Device - Product Description
  • Table 82: MicroTransponder Inc. - Ongoing Clinical Trials Overview
  • Table 83: Serenity System - Tinnitus - A Blinded Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired with Tones for Tinnitus Versus VNS with Unpaired Tones
  • Table 84: Vivistim Device - A Proof-of-concept Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired with Rehabilitation for Improved Upper Limb Function After Stroke (MicroTransponder's Vivistim System)
  • Table 85: Vivistim Device - A Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function After Stroke (MicroTransponder's Vivistim System) - Study MT-St-02 - Stroke
  • Table 86: Neurostream Technologies G.P. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Neuromodulation Device - Epilepsy - Product Status
  • Table 88: Neuromodulation Device - Epilepsy - Product Description
  • Table 89: Neuromodulation Device - Sleep Apnea - Product Status
  • Table 90: Neuromodulation Device - Sleep Apnea - Product Description
  • Table 91: Setpoint Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: SetPoint Immune System Regulator - Crohn's Disease - Product Status
  • Table 93: SetPoint Immune System Regulator - Crohn's Disease - Product Description
  • Table 94: SetPoint Immune System Regulator - Rheumatoid Arthritis - Product Status
  • Table 95: SetPoint Immune System Regulator - Rheumatoid Arthritis - Product Description
  • Table 96: Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: Equilia - Product Status
  • Table 98: Equilia - Product Description
  • Table 99: Sorin S.p.A. - Ongoing Clinical Trials Overview
  • Table 100: Equilia - Vagal Nerve Stimulation: Safe-guarding Heart Failure Patients
  • Table 101: Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Neurostimulation Device - Stroke Recovery - Product Status
  • Table 103: Neurostimulation Device - Stroke Recovery - Product Description
  • Table 104: Glossary

List of Figures

  • Figure 1: Vagus Nerve Stimulators - Pipeline Products by Stage of Development
  • Figure 2: Vagus Nerve Stimulators - Pipeline Products by Territory
  • Figure 3: Vagus Nerve Stimulators - Pipeline Products by Regulatory Path
  • Figure 4: Vagus Nerve Stimulators - Pipeline Products by Estimated Approval Date
  • Figure 5: Vagus Nerve Stimulators - Ongoing Clinical Trials
Back to Top